Mohr Marketing’s “Medical-First” Depo-Provera program screens for confirmed meningioma diagnoses, ensuring firms receive ...

H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), took part in the Global Labor Market Conference (GLMC) by participating in a session titled “Human Progress and the Future ...

The Tungsten+PLUS™ platform delivers comprehensive downstream services, including MFP claims reconciliation, dispute resolution, and compliance-ready workflows. The platform provides Health Systems ...

National power prep sports program IMG Academy is paying a massive fine after being linked to a Mexican-based drug cartel.

Is your medical device company ready for the QMSR shift? Engineer Aldo Vidinha explains why "checkbox compliance" is over and how the FDA’s alignment with ISO 13485 redefines quality as a connected, ...

The U.S. Food and Drug Administration issued its first formal guidance on how to design and run clinical trials for psychedelic drugs, a move that directly clears a path for psilocybin, the active ...

The partnership combines RRG’s FDA-registered, CLIA-certified laboratory and industry-leading biologic products with ...

Attorneys at Sidley Austin LLP examine the issue of drug price reporting rules under Medicaid and enforcement risks under the False Claims Act.

The U.S. Food and Drug Administration (FDA) released its Human Foods Program (HFP) 2026 Priority Deliverables on January 23, ...

As patient interest in regenerative medicine accelerates nationwide and regulatory scrutiny continues to intensify, Hyagen ...

The FDA underwent significant changes during the first year of the second Trump administration, directly affecting business ...